CIPRODAC 500 TABLET

Valsts: Malaizija

Valoda: angļu

Klimata pārmaiņas: NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

Nopērc to tagad

Lietošanas instrukcija Lietošanas instrukcija (PIL)
01-11-2023
Produkta apraksts Produkta apraksts (SPC)
14-11-2022

Aktīvā sastāvdaļa:

CIPROFLOXACIN HYDROCHLORIDE

Pieejams no:

PAHANG PHARMACY SDN. BHD.

SNN (starptautisko nepatentēto nosaukumu):

CIPROFLOXACIN HYDROCHLORIDE

Vienības iepakojumā:

100Tablet Tablets

Ražojis:

CADILA PHARM LTD

Lietošanas instrukcija

                                _CONSUMER MEDICATION INFORMATION LEAFLET (RIMUP) _
CIPRODAC TABLET
Ciprofloxacin Hydrochloride (500mg)
WHAT IS IN THIS LEAFLET
1.
What
_Ciprodac _
is used for
2.
How
_Ciprodac _
works
3.
Before you use
_Ciprodac _
4.
How to use
_Ciprodac _
5.
While you are using it
6.
Side effects
7.
Storage and Disposal of
_Ciprodac _
8.
Product Description
9.
Manufacturer
and
Product
Registration Holder
10.
Date of revision
WHAT _CIPRODAC _IS USED FOR
_Ciprodac _
is used to treat:

bacterial infection in blood

respiratory tract infections

kidney or urinary tract infection

genital
organs
infections,
including inflammation of uterus,
sexually
transmitted
infection,
inflammation of the prostate

stomach, intestine and abdomen
infection

skin and soft tissue infections

bone and joint infections

eyes, ear, or sinus infections

anthrax
inhalation
exposure
in
adults and in children
HOW _CIPRODAC _WORKS
_Ciprodac _
contains
the
active
ingredient, ciprofloxacin, which is an
antibiotic
belonging
to
a
group
of
medicines called quinolones.
This medicine works by killing the
bacteria which cause these infections.
BEFORE YOU USE _CIPRODAC _
_ _

_When you must not use Ciprodac _
_ _
Do not take this medicine if:

you are allergic to ciprofloxacin,
to other quinolone medicines or
to any of the other ingredients of
this medicine (listed in Product
Description)

you
have
history
of
tendon
rupture or inflammation
Do not give to children or growing
teenagers
PREGNANCY AND LACTATION
Avoid
the
use
of
Ciprodac
during
pregnancy. Tell your doctor if you are
pregnant, planning to get pregnant or
think that you might be pregnant.
Do
not
take
_Ciprodac_
during
breast
feeding
because
ciprofloxacin
is
secreted into breast milk and may cause
harm to your child.

_Before you start to use it _
_ _
Tell your doctor if you:

suffer
from
epilepsy
or
other
neurological disorder

have kidney problems

are organ transplant recipients.

have
been
diagnosed
with
an
enlargement or “bulge” of a large
blood ves
                                
                                Izlasiet visu dokumentu
                                
                            

Produkta apraksts

                                For the use only of a Registered Medical Practitioner or a
Hospital or a Laboratory only.
CIPRODAC 500
TABLET
COMPOSITION:
Each film-coated tablet contains:
Ciprofloxacin Hydrochloride USP
equivalent to Ciprofloxacin 500 mg
White-coloured, special capsule-shaped, smooth film-coated
tablet, plain on both sides.
ACTIONS AND PHARMACOLOGY:
Ciprofloxacin is a synthetic broad spectrum fluoroquinolone
antibacterial agent which is active against a wide range of
gram-positive and gram negative organisms. Its bactericidal
activity is a result of the inhibition of the A-subunit of the enzyme
DNAgyrase.
DNA-gyrase is a type II topoisomerase essential for ATP-
dependent coiling and supercoiling of bacterial DNA, a process
which enables it to be replicated and repacked in both daughter
cells. Ciprofloxacin inhibits relaxation of supercoiled DNA and
promotes double-stranded DNA breakage.
IN VITRO STUDIES HAVE SHOWN THE SUSCEPTIBILITY OF MOST
STRAINS OF THE FOLLOWING ORGANISMS:
GRAM-NEGATIVE : Escherichia coli, Klebsiella species
(including, respectively, Klebsiella pneumoniae and Klebsiella
oxytoca), Enterobacter species, Citrobacter species,
Edwardsiella
tarda, Salmonella species, Shigella species,
Proteus mirabilis, Proteus vulgaris, Providencia stuartii,
Providencia rettgeri, Morganella morganii, Serratia species
(including Serratia marcescens), Yersinia enterocolitica,
Pseudomonas aeruginosa, Acinetobacter species,
Haemophilus influenzae, Haemophilus parainfluenzae,
Haemophilus ducreyi, Neisseria gonorrhoea, Neisseria
meningitides, Branhamella catarrhalis, Campylobacter
species, Aeromonas species, Vibrio species (including
V.cholerae), Brucella melitensis, Pasteurella multocida and
Legionella species, Brucella species susceptibility is marginal.
GRAM-POSITIVE: Staphylococcus aureus (including resistant
and non-resistant to methicillin), Staphylococcus species
(including Staphylococcus epidermidis), Streptococcus
pyogenes and Streptococcus pneumoniae.
Most Streptococcus strains, including Streptococcus faecalis,
are
                                
                                Izlasiet visu dokumentu
                                
                            

Dokumenti citās valodās

Lietošanas instrukcija Lietošanas instrukcija malajiešu 01-11-2023

Meklēt brīdinājumus, kas saistīti ar šo produktu

Skatīt dokumentu vēsturi